DK0734259T3 - Antipsykotisk fremgangsmåde - Google Patents

Antipsykotisk fremgangsmåde

Info

Publication number: DK0734259T3
Authority: DK; Denmark
Prior art keywords: mammal; antipsychotic method; antipsychotic; schizophrenia; sulphur
Prior art date: 1993-08-19

Application number

DK94924708T

Other languages

Danish (da)

English (en)

Inventor

Franklin Porter Bymaster

Harlan E Shannon

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-08-19

Filing date

1994-08-15

Publication date

2002-09-30

1994-08-15 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

2002-09-30 Application granted granted Critical

2002-09-30 Publication of DK0734259T3 publication Critical patent/DK0734259T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

DK94924708T 1993-08-19 1994-08-15 Antipsykotisk fremgangsmåde DK0734259T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10930093A	1993-08-19	1993-08-19
PCT/DK1994/000305 WO1995005174A1 (fr)	1993-08-19	1994-08-15	Procede de traitement antipsychotique

Publications (1)

Publication Number	Publication Date
DK0734259T3 true DK0734259T3 (da)	2002-09-30

Family

ID=22326932

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94924708T DK0734259T3 (da)	1993-08-19	1994-08-15	Antipsykotisk fremgangsmåde

Country Status (23)

Country	Link
EP (1)	EP0734259B1 (fr)
JP (1)	JP3126736B2 (fr)
KR (1)	KR100360575B1 (fr)
CN (1)	CN1087936C (fr)
AT (1)	ATE218864T1 (fr)
AU (1)	AU701292B2 (fr)
CA (1)	CA2169839C (fr)
CZ (1)	CZ285030B6 (fr)
DE (1)	DE69430816T2 (fr)
DK (1)	DK0734259T3 (fr)
ES (1)	ES2177581T3 (fr)
FI (2)	FI960747L (fr)
HU (1)	HU221729B1 (fr)
IL (1)	IL110708A (fr)
NO (1)	NO312706B1 (fr)
NZ (2)	NZ336597A (fr)
PT (1)	PT734259E (fr)
RU (1)	RU2191580C2 (fr)
SG (1)	SG55071A1 (fr)
TW (1)	TW442284B (fr)
UA (1)	UA63876C2 (fr)
WO (1)	WO1995005174A1 (fr)
ZA (1)	ZA946324B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5821371A (en) *	1994-10-24	1998-10-13	Eli Lilly And Comany	Heterocyclic compounds and their preparation and use
US5998404A (en)	1994-10-24	1999-12-07	Eli Lilly And Company	Heterocyclic compounds and their use
US5605908A (en) *	1994-10-24	1997-02-25	Eli Lilly And Company	Heterocyclic compounds and their use
AU4139096A (en) *	1994-10-31	1996-05-23	Eli Lilly And Company	Method for treating anxiety
US5726193A (en) *	1994-10-31	1998-03-10	Eli Lilly And Company	Method for treating anxiety
US5488056A (en) *	1994-10-31	1996-01-30	Eli Lilly And Company	Method for treating anxiety
US5574028A (en) *	1994-10-31	1996-11-12	Eli Lilly And Company	Method for treating anxiety
US5565475A (en) *	1994-11-08	1996-10-15	Muhlhauser; Mark A.	Method of treating urinary bladder dysfunctions with 3-tetrahydropyridine derivatives
US5852037A (en) *	1995-11-13	1998-12-22	Eli Lilly And Company	Method for treating anxiety
US5763457A (en) *	1995-11-13	1998-06-09	Eli Lilly And Company	Method for treating anxiety
EP0821959A3 (fr) *	1996-08-01	1998-09-16	Eli Lilly And Company	Utilisation de la 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tétrahydro-1-méthylpyridine pour traiter le sevrage à la nicotine
EP0821954A1 (fr) *	1996-08-01	1998-02-04	Eli Lilly And Company	Méthode de traitement d'arriération mentale
PT821955E (pt) *	1996-08-01	2002-07-31	Lilly Co Eli	Uso de 3-(4-hexiloxi-1,2,5-tiadiazol-3-il)-1,2,5,6-tetrahidro-1-metilpiridina (xanomelina) para o tratamento da doenca bipolar
EP0821957A3 (fr) *	1996-08-01	1998-04-22	Eli Lilly And Company	Utilisation de la 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tétrahydro-1-méthylpyridine (xanoméline) pour traiter l'abus de drogues
US6043258A (en) *	1996-08-01	2000-03-28	Eli Lilly And Company	Method for treating disruptive behavior disorders with xanomeline
EP0821956A1 (fr) *	1996-08-01	1998-02-04	Eli Lilly And Company	Méthode de traitement de troubles disruptifs de comportement
US6090829A (en) *	1996-08-01	2000-07-18	Eli Lilly And Company	Method for treating excessive aggression
US6117890A (en) *	1996-08-01	2000-09-12	Eli Lilly And Company	Method for treating bipolar disorder
EP0821958A3 (fr) *	1996-08-01	1998-07-08	Eli Lilly And Company	Utilisation de la 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tétrahydro-1-méthylpyridine (xanoméline) pour traiter l'agressivité excessive
WO1998053820A1 (fr) *	1997-05-29	1998-12-03	H. Lundbeck A/S	Traitement de la schizophrenie et de la psychose
US6034108A (en) *	1997-07-28	2000-03-07	Eli Lilly And Company	Method for treating mental retardation
PL3061821T3 (pl)	2009-07-22	2020-01-31	PureTech Health LLC	Kompozycje do leczenia zaburzeń łagodzonych przez aktywację receptora muskarynowego
JP7096441B2 (ja) *	2018-09-28	2022-07-05	カルナセラピューティックス，インコーポレイテッド	ムスカリン受容体活性化によって改善される障害を処置するための組成物及び方法
US11534434B2 (en)	2019-11-15	2022-12-27	Karuna Therapeutics, Inc.	Xanomeline derivatives and methods for treating neurological disorders
WO2023061372A1 (fr) *	2021-10-14	2023-04-20	南京迈诺威医药科技有限公司	Sel de malate de dérivé de xanoméline, forme cristalline a, procédé de préparation correspondant et utilisation associée
CN119161338B (zh) *	2024-11-25	2025-06-17	嘉兴安帝康生物科技有限公司	用作毒蕈碱受体激动剂的四氢吡啶衍生物及其在医药上的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ225999A (en) *	1987-09-10	1992-04-28	Merck Sharp & Dohme	Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions
US5043345A (en) *	1989-02-22	1991-08-27	Novo Nordisk A/S	Piperidine compounds and their preparation and use
DK198390D0 (da) *	1990-08-21	1990-08-21	Novo Nordisk As	Heterocykliske forbindelser, deres fremstilling og anvendelse
DK198490D0 (da) *	1990-08-21	1990-08-21	Novo Nordisk As	Heterocykliske forbindelser, deres fremstilling og anvendelse

1994
- 1994-08-15 NZ NZ336597A patent/NZ336597A/en unknown
- 1994-08-15 SG SG1996004738A patent/SG55071A1/en unknown
- 1994-08-15 RU RU96105388/14A patent/RU2191580C2/ru not_active IP Right Cessation
- 1994-08-15 CN CN94193733A patent/CN1087936C/zh not_active Expired - Fee Related
- 1994-08-15 CA CA002169839A patent/CA2169839C/fr not_active Expired - Fee Related
- 1994-08-15 FI FI960747A patent/FI960747L/fi not_active Application Discontinuation
- 1994-08-15 HU HU9600364A patent/HU221729B1/hu not_active IP Right Cessation
- 1994-08-15 UA UA96020584A patent/UA63876C2/uk unknown
- 1994-08-15 KR KR1019960700806A patent/KR100360575B1/ko not_active Expired - Fee Related
- 1994-08-15 NZ NZ271311A patent/NZ271311A/en not_active IP Right Cessation
- 1994-08-15 JP JP07506691A patent/JP3126736B2/ja not_active Expired - Lifetime
- 1994-08-15 DK DK94924708T patent/DK0734259T3/da active
- 1994-08-15 EP EP94924708A patent/EP0734259B1/fr not_active Expired - Lifetime
- 1994-08-15 AU AU74902/94A patent/AU701292B2/en not_active Ceased
- 1994-08-15 WO PCT/DK1994/000305 patent/WO1995005174A1/fr not_active Ceased
- 1994-08-15 ES ES94924708T patent/ES2177581T3/es not_active Expired - Lifetime
- 1994-08-15 DE DE69430816T patent/DE69430816T2/de not_active Expired - Lifetime
- 1994-08-15 CZ CZ96426A patent/CZ285030B6/cs not_active IP Right Cessation
- 1994-08-15 PT PT94924708T patent/PT734259E/pt unknown
- 1994-08-15 AT AT94924708T patent/ATE218864T1/de not_active IP Right Cessation
- 1994-08-18 IL IL11070894A patent/IL110708A/en not_active IP Right Cessation
- 1994-08-19 ZA ZA946324A patent/ZA946324B/xx unknown
1995
- 1995-02-15 TW TW084101387A patent/TW442284B/zh not_active IP Right Cessation
1996
- 1996-02-16 NO NO19960619A patent/NO312706B1/no not_active IP Right Cessation
2005
- 2005-04-29 FI FI20050461A patent/FI20050461L/fi not_active Application Discontinuation

Also Published As

Publication number	Publication date
IL110708A0 (en)	1994-11-11
CN1133008A (zh)	1996-10-09
AU701292B2 (en)	1999-01-21
NZ336597A (en)	2001-02-23
FI20050461A7 (fi)	2005-04-29
NO960619L (no)	1996-04-18
RU2191580C2 (ru)	2002-10-27
CN1087936C (zh)	2002-07-24
CZ42696A3 (en)	1996-11-13
NO312706B1 (no)	2002-06-24
EP0734259A1 (fr)	1996-10-02
ES2177581T3 (es)	2002-12-16
HU221729B1 (hu)	2002-12-28
FI960747A7 (fi)	1996-04-17
DE69430816T2 (de)	2002-12-19
EP0734259B1 (fr)	2002-06-12
FI960747A0 (fi)	1996-02-19
FI20050461L (fi)	2005-04-29
NO960619D0 (no)	1996-02-16
CZ285030B6 (cs)	1999-05-12
IL110708A (en)	1998-12-06
JPH09501658A (ja)	1997-02-18
JP3126736B2 (ja)	2001-01-22
UA63876C2 (en)	2004-02-16
CA2169839C (fr)	2002-06-11
DE69430816D1 (de)	2002-07-18
HUT75111A (en)	1997-04-28
CA2169839A1 (fr)	1995-02-23
HU9600364D0 (en)	1996-04-29
FI960747L (fi)	1996-04-17
AU7490294A (en)	1995-03-14
ZA946324B (en)	1996-02-19
NZ271311A (en)	1999-09-29
PT734259E (pt)	2002-11-29
WO1995005174A1 (fr)	1995-02-23
KR960703592A (ko)	1996-08-31
ATE218864T1 (de)	2002-06-15
KR100360575B1 (ko)	2003-03-10
TW442284B (en)	2001-06-23
SG55071A1 (en)	1998-12-21

Publication	Publication Date	Title
DK0734259T3 (da)	2002-09-30	Antipsykotisk fremgangsmåde
EP0604641A4 (fr)	1995-08-02	Composition contenant des derives amines ou apparentes aux amines d'acide benzoique et utilisations, y compris dans le traitement de maladies inflammatoires.
EP0613883A4 (fr)	1994-12-07	Derive d'acide hydroxamique.
DE69902634D1 (de)	2002-10-02	Substituierte aminophenylisoxazolinderivate verwendbar als antimikrobielle agenzien
FI903215A0 (fi)	1990-06-26	Heteroarylamino- och heteroaryloxipyridinaminer och till desa hoerande foereningar, foerfarande foer deras framstaellning samt deras anvaendning som laekemedel.
IL99525A0 (en)	1992-08-18	Fused ring analogs of nitrogen containing nonaromatic heterocycles
FI960748A0 (fi)	1996-02-19	Antipsykoottinen menetelmä
TW232013B (fr)	1994-10-11
IT1264563B1 (it)	1996-10-04	Composti fotocromatici e metodo per la loro preparazione
BR9611472A (pt)	1999-02-02	Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios
ATE169217T1 (de)	1998-08-15	Verwendung von furanonderivaten zur vorbeugung oder behandlung von autoimmunkrankheiten
DE69019920D1 (de)	1995-07-13	Benzocycloalkylaminopyridinamine und verwandte Verbindungen, Verfahren zu ihrer Herstellung, Zwischenverbindungen und ihre Verwendung als Arzneimittel.
NO20003481L (no)	2000-08-25	FremgangsmÕte for behandling av COPD
DE68911237D1 (de)	1994-01-20	Nichtionische Trijodbenzin-Verbindungen und diese enthaltende Kontrastmittel.
ES2123728T3 (es)	1999-01-16	Derivados de pirrolo-pirazina de actividad 5-ht3.
DE68921051D1 (de)	1995-03-23	Pyridin-3-percarboxylsäure monopersulfat.
ATE50762T1 (de)	1990-03-15	3-(indan-5-yloxy (oder thio)>cyclopentancarbons\|ure-analogeund sie enthaltendes behandlungsmittel.
MX9709275A (es)	1998-03-29	Uso de los derivados del acido sulfamico, carbamatos acil sulfonamidas o sulfonil para la manufactura de un medicamento para disminuir los niveles de lipoproteinas.